Iroko Pharmaceuticals (IRKO) Withdrawn

Developing high-efficacy, low-dose NSAID therapeutics.

Health Care -

IPO Performance
Latest Trade ()
First Day Return
Return from IPO
 
Iroko Pharmaceuticals IPO News more
  • .
IPO Data
IPO File Date 06/18/2013
Offer Price
Price Range n/a
Offer Shares (mm) n/a
Deal Size ($mm) n/a
 
IPO Data
IPO Date
Offer Price
Price Range n/a
Offer Shares (mm) n/a
Deal Size ($mm) $n/a
 
Underwriters
more
Business Overview
Developing high-efficacy, low-dose NSAID therapeutics.
Developing high-efficacy, low-dose NSAID therapeutics.
more
Company Data
Headquarters Philadelphia, PA
Founded 2007
Employees 71
Website www.iroko.com
 

Performance vs. IPO Index (IPOUSA)